NKGen Biotech Inc (NKGN) Income Statement











0.000

Close （ET）Quotes delayed by 15 min

--Market Cap

--P/E TTM



0.000

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Statements

Income Statement

Balance Sheet

Cash Flow Statement

You can find the annual or quarterly income statement of undefined here for insights into the performance and operational efficiency of undefined.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

Total revenue

----

--0.00

-100.00%0.00

----

--0.00

--3.00K

Revenue

----

--0.00

-100.00%0.00

----

--0.00

--3.00K

Cost of revenue

----

-100.00%0.00

--0.00

----

--15.00K

--0.00

Operating expenses

-45.93%5.10M

-1.67%6.79M

12.80%7.46M

12.11%7.62M

50.67%9.43M

15.15%6.90M

--6.61M

--6.80M

--6.26M

--6.00M

R&D expenses

-61.97%1.56M

-29.29%2.78M

-23.78%3.09M

-10.09%3.24M

0.10%4.09M

-4.66%3.93M

--4.05M

--3.60M

--4.09M

--4.12M

Depreciation, depletion, and amortization

33.33%400.00K

0.00%300.00K

-1.32%300.00K

-1.96%300.00K

0.00%300.00K

--300.00K

--304.00K

--306.00K

--300.00K

Operating profit

45.93%-5.10M

1.67%-6.79M

-12.80%-7.46M

-12.11%-7.62M

-50.67%-9.43M

-15.20%-6.90M

---6.61M

---6.80M

---6.26M

---5.99M

Net non-operating interest income (expenses)

Non-operating interest expense

22.37%536.00K

123.70%472.00K

943.55%647.00K

3044.12%1.07M

-28.90%438.00K

-66.82%211.00K

--62.00K

--34.00K

--616.00K

--636.00K

Special income (expenses)

0.02%-23.73M

153.17%13.86M

-522.29%-7.98M

321.65%3.33M

-26561.80%-23.73M

-35602.74%-26.06M

---1.28M

---1.50M

---89.00K

---73.00K

Other non-operating income (expenses)

--0.00

-100.00%0.00

-272.73%-19.00K

-100.00%0.00

--107.00K

--11.00K

--24.00K

--8.00K

Income before tax

12.61%-29.36M

119.89%6.60M

-104.97%-16.09M

35.33%-5.38M

-384.07%-33.60M

-395.70%-33.18M

---7.85M

---8.32M

---6.94M

---6.69M

Income tax

657.14%53.00K

--0.00

----

0.00%7.00K

--0.00

----

--7.00K

--0.00

Income after tax

12.47%-29.41M

119.89%6.60M

-104.97%-16.09M

35.33%-5.38M

-383.68%-33.61M

-395.70%-33.18M

---7.85M

---8.32M

---6.95M

---6.69M

Net income from continuous operations

12.47%-29.41M

119.89%6.60M

-104.97%-16.09M

35.33%-5.38M

-383.68%-33.61M

-395.70%-33.18M

---7.85M

---8.32M

---6.95M

---6.69M

Net income attributable to controlling interests

12.47%-29.41M

119.89%6.60M

-104.97%-16.09M

35.33%-5.38M

-383.68%-33.61M

-395.70%-33.18M

---7.85M

---8.32M

---6.95M

---6.69M

Net income attributable to common shareholders

12.47%-29.41M

119.89%6.60M

-104.97%-16.09M

35.33%-5.38M

-383.68%-33.61M

-395.70%-33.18M

---7.85M

---8.32M

---6.95M

---6.69M

Basic earnings per share

44.06%-0.74

114.94%0.23

-71.16%-0.67

40.50%-0.25

-281.99%-1.32

-357.06%-1.52

---0.39

---0.41

---0.34

---0.33

Diluted earnings per share

44.06%-0.74

110.53%0.16

-71.16%-0.67

40.50%-0.25

-281.99%-1.32

-357.06%-1.52

---0.39

---0.41

---0.34

---0.33

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

